Incomplete and partial hydatidiform mole
ICD-10 O01.1 is a billable code used to indicate a diagnosis of incomplete and partial hydatidiform mole.
An incomplete or partial hydatidiform mole is a type of gestational trophoblastic disease characterized by abnormal placental development and the presence of some fetal tissue. This condition arises when there is an abnormal fertilization event, leading to the formation of a placenta that is either partially developed or contains both normal and abnormal tissue. Clinically, patients may present with symptoms such as vaginal bleeding, elevated levels of human chorionic gonadotropin (hCG), and an enlarged uterus. Diagnosis is typically confirmed through ultrasound, which may reveal a heterogeneous mass within the uterus. The risk of developing choriocarcinoma, a malignant form of gestational trophoblastic disease, is a significant concern, necessitating careful monitoring of hCG levels post-diagnosis. Management often involves surgical intervention, such as dilation and curettage (D&C), to remove the abnormal tissue, followed by regular hCG monitoring to ensure complete resolution and to detect any potential malignant transformation early.
Detailed documentation of symptoms, ultrasound findings, and hCG levels is essential for accurate coding.
Patients presenting with abnormal bleeding in early pregnancy, requiring ultrasound evaluation.
Coders must ensure that all relevant clinical details are captured to support the diagnosis and treatment plan.
Comprehensive documentation of maternal and fetal health, including any complications arising from the mole.
Management of high-risk pregnancies where molar pregnancies are suspected or diagnosed.
High-risk factors must be documented to justify the complexity of care and coding.
Used for the surgical management of incomplete hydatidiform moles.
Document indication for D&C, findings, and post-operative care.
Obstetricians should ensure that the procedure is well-documented to support the diagnosis.
hCG monitoring is crucial in incomplete hydatidiform moles to ensure that the abnormal tissue is completely removed and to detect any potential malignant transformation into choriocarcinoma. Regular monitoring helps in timely intervention if hCG levels do not decline as expected.
